Genmab A/S (GMAB) — Cash Flow Quality Index
Genmab A/S (GMAB) has a Cash Flow Quality Index of 1.11x as of September 2025. Operating cash flow of Dkr536.00 Million exceeds net income of Dkr482.00 Million, indicating high earnings quality where cash backs reported profits. Explore Genmab A/S (GMAB) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genmab A/S Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Genmab A/S across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GMAB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Genmab A/S (2013–2024)
Year-by-year earnings quality comparison for Genmab A/S. For live market cap and the full company financial profile, see market cap of Genmab A/S.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | Dkr7.77 Billion | Dkr7.84 Billion | ▼ -24.3% |
| 2023 | 1.31x | Dkr7.38 Billion | Dkr5.64 Billion | ▲ +135.4% |
| 2022 | 0.56x | Dkr3.91 Billion | Dkr7.04 Billion | ▼ -0.6% |
| 2021 | 0.56x | Dkr2.23 Billion | Dkr3.98 Billion | ▼ -48.7% |
| 2020 | 1.09x | Dkr6.43 Billion | Dkr5.90 Billion | ▲ +134.9% |
| 2019 | 0.46x | Dkr1.33 Billion | Dkr2.86 Billion | ▼ -26.3% |
| 2018 | 0.63x | Dkr1.01 Billion | Dkr1.61 Billion | ▼ -57.9% |
| 2017 | 1.49x | Dkr1.59 Billion | Dkr1.06 Billion | ▲ +415.2% |
| 2016 | 0.29x | Dkr327.72 Million | Dkr1.13 Billion | ▼ -29.5% |
| 2015 | 0.41x | Dkr311.45 Million | Dkr757.53 Million | ▼ -7.9% |
| 2014 | 0.45x | Dkr132.67 Million | Dkr297.35 Million | ▲ +137.5% |
| 2013 | -1.19x | Dkr-128.00 Million | Dkr107.64 Million | — |